KeyCorp Has Bearish Estimate for Corteva FY2026 Earnings

Corteva, Inc. (NYSE:CTVA – Free Report) – Stock analysts at KeyCorp reduced their FY2026 earnings per share estimates for Corteva in a report issued on Sunday, November 15th. KeyCorp analyst S. Tiano now expects that the company will earn $0.79 per share for the year, down from their previous estimate of $1.07. KeyCorp has an “Overweight” rating and a $14.00 price objective on the stock. The consensus estimate for Corteva’s current full-year earnings is $0.98 per share. KeyCorp also issued estimates for Corteva’s FY2027 earnings at $0.75 EPS, FY2028 earnings at $0.90 EPS and FY2029 earnings at $1.20 EPS.

Other equities research analysts have also issued research reports about the company. Mizuho set a $16.00 price objective on Corteva in a report on Thursday, November 12th. Zacks Research downgraded shares of Corteva from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 6th. Oppenheimer lowered shares of Corteva from an “outperform” rating to a “market perform” rating in a research report on Friday, November 13th. Deutsche Bank reiterated a “buy” rating and set a $101.00 target price on shares of Corteva in a research report on Monday, August 3rd. Finally, Citigroup reduced their target price on shares of Corteva from $13.65 to $10.30 and set a “neutral” rating for the company in a research note on Friday, November 13th. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $48.83.

Read Our Latest Stock Report on Corteva

Corteva Stock Down 2.8%

Shares of NYSE CTVA opened at $8.12 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.56 and a quick ratio of 1.08. The stock has a market capitalization of $5.42 billion, a PE ratio of 2.10, a P/E/G ratio of 1.25 and a beta of 0.58. Corteva has a one year low of $8.03 and a one year high of $90.97. The business’s fifty day moving average price is $31.05 and its 200-day moving average price is $68.27.

Corteva Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a $0.05 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $0.20 annualized dividend and a yield of 2.5%. This is a decrease from Corteva’s previous quarterly dividend of $0.18. Corteva’s dividend payout ratio is 37.89%.

Insider Buying and Selling

In related news, CEO Luther C. Iv Kissam bought 32,292 shares of Corteva stock in a transaction on Friday, November 13th. The stock was acquired at an average price of $9.30 per share, with a total value of $300,315.60. Following the acquisition, the chief executive officer directly owned 185,379 shares of the company’s stock, valued at $1,724,024.70. This represents a 21.09% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.15% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Corteva

A number of institutional investors and hedge funds have recently modified their holdings of the company. EFG International AG bought a new position in Corteva during the 2nd quarter worth approximately $25,000. Compass Financial Management LLC purchased a new position in Corteva in the 2nd quarter worth approximately $25,000. Elevation Wealth Partners LLC lifted its position in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the last quarter. Clearstead Trust LLC bought a new stake in Corteva in the second quarter valued at approximately $31,000. Finally, N.E.W. Advisory Services LLC bought a new stake in Corteva in the second quarter valued at approximately $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Corteva

Investors following CTVA have been watching these headlines:

  • Positive Sentiment: Corteva’s CEO bought about $300,316 of company stock, an insider purchase that may signal confidence in the business. Corteva CEO Buys Stock
  • Neutral Sentiment: Corteva reportedly completed a global seed-business spin-off; the provided report does not specify its financial implications. Corteva Completes Global Seed Business Spin-Off
  • Neutral Sentiment: A Seeking Alpha analysis argues that Corteva’s Brazil-related challenges may eventually ease, though it acknowledges those issues as a concern. Corteva: Brazil Issues Will Eventually Ease

About Corteva

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Read More

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.